103 related articles for article (PubMed ID: 8739818)
1. Effect of diprafenone on the pharmacokinetics of digoxin.
Koytchev R; Alken RG; Mayer O
Eur J Clin Pharmacol; 1996; 50(1-2):97-100. PubMed ID: 8739818
[TBL] [Abstract][Full Text] [Related]
2. Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone--a novel antiarrhythmic agent.
Koytchev R; Alken RG; Mayer O; Smith I; Greenwood M
Eur J Clin Pharmacol; 1996; 50(4):315-9. PubMed ID: 8803526
[TBL] [Abstract][Full Text] [Related]
3. [Effect of propafenone on the pharmacokinetics of digoxin administered orally: a study in healthy volunteers].
Cardaioli P; Compostella L; De Domenico R; Papalia D; Zeppellini R; Libardoni M; Pulido E; Cucchini F
G Ital Cardiol; 1986 Mar; 16(3):237-40. PubMed ID: 3732716
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
Trenk D; Wagner F; Sachs W; Jähnchen E
Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
[TBL] [Abstract][Full Text] [Related]
6. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
[TBL] [Abstract][Full Text] [Related]
8. Interaction between digoxin and propafenone.
Calvo MV; Martin-Suarez A; Martin Luengo C; Avila C; Cascon M; Domínguez-Gil Hurlé A
Ther Drug Monit; 1989; 11(1):10-5. PubMed ID: 2911842
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
Harder S; Thürmann PA
Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
Nanoff C; Schütz W
J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
[TBL] [Abstract][Full Text] [Related]
12. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine.
Ashforth EI; Palmer JL; Bye A; Bedding A
Br J Clin Pharmacol; 1994 Apr; 37(4):389-91. PubMed ID: 8018461
[TBL] [Abstract][Full Text] [Related]
14. Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects.
Nolan PE; Marcus FI; Erstad BL; Hoyer GL; Furman C; Kirsten EB
J Clin Pharmacol; 1989 Jan; 29(1):46-52. PubMed ID: 2708548
[TBL] [Abstract][Full Text] [Related]
15. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
Groschner K; Lindner W; Schnedl H; Kukovetz WR
Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction of sparfloxacin and digoxin.
Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
Wagner F; Jähnchen E; Trenk D
Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
[TBL] [Abstract][Full Text] [Related]
18. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
Greenberg S; Cantor E; Paul J
J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers.
Vousden M; Allen A; Lewis A; Ehren N
Chemotherapy; 1999; 45(6):485-90. PubMed ID: 10567779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
